Clinical Trial Update: The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravenous iron therapy in combination with erythropoiesis-stimulating agent for outcomes in chronic kidney disease/renal transplant c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure Chronic

Drugs mentioned

• Intravenous iron therapy (iron (intravenous))
• erythropoiesis-stimulating agent

Snippet

Sponsor: Yonsei University | Conditions: Kidney Failure, Chronic | Phase 4 | Status: NOT_YET_RECRUITING